SCHEMBL3515899

SCHEMBL3515899

CCOC(=O)CCCCCCOc1cc2c(=O)[nH]cnc2cc1OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 4/20 0.48
MMP13 P45452 1/20 0.43
EGFR P00533 2/20 0.43
HDAC3 O15379 1/20 0.43
ERBB2 P04626 1/20 0.43
KDR P35968 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
TNF P01375 4/20 0.42
IP6K3 Q96PC2 1/20 0.41
IP6K2 Q9UHH9 1/20 0.41
ROCK2 O75116 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3516603 1.00 IP6K1 (0.48) IP6K1MMP13EGFRHDAC3ERBB2
SCHEMBL13903542 0.93 IP6K1 (0.51) IP6K1MMP13EGFRTNFIP6K3
SCHEMBL3515890 0.89 IP6K1 (0.51) IP6K1EGFRHDAC3ERBB2KDR
SCHEMBL4338284 0.86 TNF (0.56) HDAC3KDRHDAC4HDAC1HDAC7
SCHEMBL642750 0.86 TNF (0.56) HDAC3KDRHDAC4HDAC1HDAC7
SCHEMBL4336232 0.85 TNF (0.50) MMP13EGFRHDAC3ERBB2HDAC4
SCHEMBL642824 0.85 TNF (0.50) MMP13EGFRHDAC3ERBB2HDAC4
SCHEMBL3517589 0.83 HDAC3 (0.48) EGFRHDAC3ERBB2KDRHDAC4
SCHEMBL3518656 0.83 HDAC3 (0.48) EGFRHDAC3ERBB2KDRHDAC4
SCHEMBL20897397 0.81 IP6K1 (0.69) IP6K1IP6K3IP6K2ROCK2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194787-A1 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY Curis, Inc. (US) 2010-06-16 EP disclosed
WO-2009036055-A1 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY CURIS, INC. (US) 2009-03-19 WO disclosed
US-20090076044-A1 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY CURIS, INC. 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076044-A1 VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY KDR, HDAC1, FLT4 IP6K1 2518/4885MMP13 584/4885EGFR 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.